Clinical trial
A Phase 2/3 Trial of d-Penicillamine Chelation in Lead-Poisoned Children
NCT00552630 is registered in ClinicalTrials.gov with FDA Office of Orphan Products Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2/3 Trial of d-Penicillamine Chelation in Lead-Poisoned Children
- Lead sponsor
- FDA Office of Orphan Products Development
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- September 30, 2007
- Completion date
- Not reported
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.